Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss.  GLP-1 medications were originally intended to ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

President-elect Donald Trump faces deep skepticism that his administration's policies will make health care more affordable, ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Hims & Hers Health (NYSE: HIMS) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. Is Hims & Hers ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 463.56% and ...

In its first financial results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group ...

Omvoh is the first biologic treatment in more than 15 years to have disclosed two-year Phase 3 efficacy data in Crohn's disease at the time of approval. 2 "The burden of Crohn's disease on patients' ...

But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...

after its investor day presentations were canceled last month by the murder of executive Brian Thompson outside the New York hotel where the meeting was set to take place. Healthcare ...

Israeli Cabinet Has Yet to Vote on Cease-Fire Deal The agreement was met with cautious optimism after 15 months of war. But the Israeli prime minister’s office said there were some last-minute ...